First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 180.35 USD 0.65% Market Closed
Updated: Mar 28, 2024

Abbvie Inc
Other Liabilities

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

Abbvie Inc
Other Liabilities Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.3B
CAGR 3-Years
5%
CAGR 5-Years
17%
CAGR 10-Years
25%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$3.3B
CAGR 3-Years
-31%
CAGR 5-Years
-14%
CAGR 10-Years
26%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$7B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.2B
CAGR 3-Years
24%
CAGR 5-Years
62%
CAGR 10-Years
32%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$980.8m
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
17%
Seagen Inc
NASDAQ:SGEN
Other Liabilities
$129.1m
CAGR 3-Years
-6%
CAGR 5-Years
68%
CAGR 10-Years
-1%

See Also

What is Abbvie Inc's Other Liabilities?
Other Liabilities
32.3B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Liabilities amounts to 32.3B USD.

What is Abbvie Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
25%

Over the last year, the Other Liabilities growth was 5%. The average annual Other Liabilities growth rates for Abbvie Inc have been 5% over the past three years , 17% over the past five years , and 25% over the past ten years .